C57BL/6NCya-Tnikem1/Cya
Common Name:
Tnik-KO
Product ID:
S-KO-11757
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tnik-KO
Strain ID
KOCMP-665113-Tnik-B6N-VA
Gene Name
Product ID
S-KO-11757
Gene Alias
1500031A17Rik; 4831440I19Rik; C530008O15Rik; C630040K21Rik
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
3
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Tnikem1/Cya mice (Catalog S-KO-11757) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000160307
NCBI RefSeq
NM_026910
Target Region
Exon 5~6
Size of Effective Region
~6.6 kb
Detailed Document
Overview of Gene Research
Traf2- and Nck-interacting kinase (TNIK) is a key regulator of pathological metabolic signaling in several diseases, making it a promising drug target [1]. It is involved in cell migration, proliferation, and differentiation, and participates in various biological processes. TNIK is a regulatory component of the transcriptional complex composed of β -catenin and T -cell factor 4 (TCF4), playing a role in the Wnt/β -catenin signaling pathway [3].
TNIK knockout mice exhibited hyperlocomotor activity and were protected against diet-induced fat expansion, insulin resistance, and hepatic steatosis. This shows that TNIK governs lipid and glucose homeostasis [2]. In injured renal proximal tubule epithelial cells, depletion of TNIK led to inflammation and apoptosis, indicating that TNIK acts to suppress inflammatory signaling and apoptosis to promote cell survival [4]. In castration-resistant prostate cancer, TNIK was found to drive cancer progression by phosphorylating EGFR [5].
In conclusion, TNIK plays essential roles in multiple biological processes such as glucose and lipid metabolism, cell survival in the context of renal injury, and cancer progression. The use of TNIK knockout mouse models has been crucial in revealing its functions in these disease-related areas, providing insights into potential therapeutic strategies for metabolic disorders, acute kidney injury, and certain cancers [2,4,5].
References:
1. Ewald, Collin Y, Pulous, Fadi E, Lok, Sarah Wing Yan, Ren, Feng, Zhavoronkov, Alex. 2024. TNIK's emerging role in cancer, metabolism, and age-related diseases. In Trends in pharmacological sciences, 45, 478-489. doi:10.1016/j.tips.2024.04.010. https://pubmed.ncbi.nlm.nih.gov/38777670/
2. Pham, T C Phung, Dollet, Lucile, Ali, Mona S, Havula, Essi, Sylow, Lykke. 2023. TNIK is a conserved regulator of glucose and lipid metabolism in obesity. In Science advances, 9, eadf7119. doi:10.1126/sciadv.adf7119. https://pubmed.ncbi.nlm.nih.gov/37556547/
3. Kukimoto-Niino, Mutsuko, Shirouzu, Mikako, Yamada, Tesshi. 2022. Structural Insight into TNIK Inhibition. In International journal of molecular sciences, 23, . doi:10.3390/ijms232113010. https://pubmed.ncbi.nlm.nih.gov/36361804/
4. Bradford, Shayna T J, Wu, Haojia, Kirita, Yuhei, Muto, Yoshiharu, Humphreys, Benjamin D. 2024. TNIK depletion induces inflammation and apoptosis in injured renal proximal tubule epithelial cells. In American journal of physiology. Renal physiology, 326, F827-F838. doi:10.1152/ajprenal.00262.2023. https://pubmed.ncbi.nlm.nih.gov/38482555/
5. Guo, Jianing, Liang, Jiaming, Wang, Youzhi, Niu, Yuanjie, Jiang, Ning. 2023. TNIK drives castration-resistant prostate cancer via phosphorylating EGFR. In iScience, 27, 108713. doi:10.1016/j.isci.2023.108713. https://pubmed.ncbi.nlm.nih.gov/38226156/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen